Show simple item record

dc.contributor.authorLoveridge, R.
dc.contributor.authorNethercott, D.
dc.contributor.authorMoore, C.
dc.contributor.authorDarwin, L.
dc.contributor.authorEkambaram, R.
dc.contributor.authorFaulkner, G.
dc.contributor.authorAllen, Jonathan
dc.contributor.authorForrest, C.
dc.contributor.authorMoore, J.
dc.date.accessioned2021-10-28T09:26:09Z
dc.date.available2021-10-28T09:26:09Z
dc.date.issued2021en
dc.identifier.citationLoveridge R, Nethercott D, Moore C, Darwin L, Ekambaram R, Faulkner G, et al. System-wide implementation of ERAS plus in Greater Manchester. Anaesthesia. 2021;76:21-.en
dc.identifier.urihttp://hdl.handle.net/10541/624697
dc.description.abstractWith the damaging impact of COVID-19 on elective surgery globally, it is vital that we delivermajor surgical care that supports patients, minimises complications and reduces hospital lengthof stay (LOS). Enhanced Recovery After Surgery (ERAS) processes [1] provide a means of doingthis and the UK ERAS+ peri-operative pathway (www.erasplus.co.uk), which includes a particularemphasis on patient preparation using the surgery school education tool and pre-habilitationelements, has been shown in a single centre to reduce peri-operative pulmonary complications(PPC) and improve hospital LOS [2]. MethodsIn 2017, ERAS+ Greater Manchester (GM), was awarded Health Foundation Scaling Up fundingfor the implementation of ERAS+ in six NHS hospitals across GM. Beginning in January 2018,quality improvement and operational partners alongside an expert ERAS+ team worked withsite teams in two overlapping phases (three hospitals in each) to support the integration ofERAS+ into colorectal surgical oncological pathways in all six sites, and ERAS+ into lung andupper GI cancer surgical oncological pathways in two of the hospitals. The site ERAS+ teamconsisted of peri-operative anaesthetist, surgeon, ERAS nurse, allied health professionals and ahealth foundation funded data audit clerk.ResultsFig. 1 shows the results of aggregate LOS data for colorectal cancer resection surgery for ?veof the hospital sites (A, C, D, E and F), which undertook ERAS+ from 2018 onwards (no. ofpatients = 1328) and for which Trust historical LOS data were available. The completion pointsfor the initial two phases of implementation of ERAS+ are demonstrated. For the ?ve-sitesshown, the baseline mean LOS was 12.1 days. There was an aggregate reduction in LOS to9.0 days, a reduction of 3.1 days, associated with a reduction in PPC. Patient measured satisfac-tion with ERAS+ was excellent and there was no increase in re-admission rates associated withLOS reduction. Factorial design methodology was used to compare combinations of processmeasures patients received against LOS. Generally, a lower LOS occurred where patients (1)were mobilised within 24 h post-surgery, (2) started an oral diet within 24 h after surgery and(3) attended Surgery School before admission. DiscussionERAS+ has been implemented successfully at a system level in GM for colorectal cancerpatients, with an aggregate LOS reduction of over 3 days, which was associated with reducedrate of PPC.en
dc.language.isoenen
dc.titleSystem-wide implementation of ERAS plus in Greater Manchesteren
dc.typeOtheren
dc.contributor.departmentStockport NHS Foundation Trusten
dc.identifier.journalAnaesthesiaen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record